Paper: A Pilot Study of the Anti-SLAMF7 Monoclonal Antibody, Elotuzumab, in Myelofibrosis -

Oral and Poster Abstracts 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Clinical Trials, Biological, Antibody Therapy, Translational Research, Clinical Research, Clinically Relevant, Diseases, Therapies, Myeloid Malignancies Prithviraj Bose, MD1, Taghi Manshouri, PhD1*, Sharon D. Bledsoe2*, Nitin Jain, MD1, Lucia...